Table 3.

The level of serum Cys-C in BUT patients with normal GFR.

Parameters	Number of patients	Cys-C	P
		levels (mg/L, mean ± SD)
Age			0.001
<60 yr.	144	0.88 ± 0.15
≥60 yr.	177	0.94 ± 0.14
Sex			0.012
Male	263	0.92 ± 0.14
Female	58	0.87 ± 0.15
Smoking history			0.233
Never	204	0.91 ± 0.15
Ever	117	0.93 ± 0.15
Painless macroscopic hematuria			0.101
No	59	0.89 ± 0.13
Yes	262	0.92 ± 0.15
WBC counta			0.149
<6.08 × 109/L	160	0.90 ± 0.14
≥6.08 × 109/L	161	0.93 ± 0.15
PLT counta			0.568
<216 × 109/L	160	0.92 ± 0.15
≥216 × 109/L	161	0.91 ± 0.14
PFLa			0.023
<2.88 g/L	161	0.90 ± 0.15
≥2.88 g/L	160	0.93 ± 0.15
Tumor number			0.541
Single	229	0.92 ± 0.13
Multiple	92	0.91 ± 0.16
Tumor sizea			0.619
<2 cm	101	0.91 ± 0.15
≥2 cm	218	0.92 ± 0.15
Pathological characteristics			0.733
Papilloma	21	0.89 ± 0.17
PUNLMP	60	0.91 ± 0.14
BUC	240	0.92 ± 0.15
Grade			0.390
Low-grade	141	0.91 ± 0.14
High-grade	99	0.93 ± 0.15
Stage			0.913
Ta	140	0.92 ± 0.79
T1	62	0.92 ± 0.16
T2	27	0.90 ± 0.13
T3	7	0.87 ± 0.20
T4	4	0.90 ± 0.08

Continuous variables are expressed as median ^a. Bold values are statistically significant (P < 0.05). PUNLMP: papillary urothelial neoplasm of low malignant potential; BUC: bladder urothelial carcinoma; WBC: white blood cell; PLT: platelet; PFL: plasma fibrinogen levels.